GDRX GoodRx Holdings Inc

Price (delayed)

$3.32

Market cap

$1.13B

P/E Ratio

66.4

Dividend/share

N/A

EPS

$0.05

Enterprise value

$1.38B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 56
Highlights
GoodRx Holdings's equity has increased by 4.1% from the previous quarter
The quick ratio has plunged by 89% YoY and by 25% from the previous quarter
The price to earnings (P/E) is 59% higher than the last 4 quarters average of 43.3

Key stats

What are the main financial stats of GDRX

GDRX stock price

How has the GoodRx Holdings stock price performed over time
Intraday
-3.49%
1 week
-2.06%
1 month
-3.77%
1 year
-17.82%
YTD
22.51%
QTD
15.28%

Financial performance

How have GoodRx Holdings's revenue and profit performed over time
Revenue
$785.23M
Gross profit
$713.19M
Operating income
$74.97M
Net income
$16.25M
Gross margin
90.8%
Net margin
2.1%
GoodRx Holdings's net income has shrunk by 53% YoY and by 21% QoQ
The net margin has plunged by 51% YoY and by 19% from the previous quarter
The company's operating income fell by 13% YoY and by 4.1% QoQ
The operating margin has decreased by 12% YoY and by 4% QoQ

Price vs fundamentals

How does GDRX's price correlate with its fundamentals

Growth

What is GoodRx Holdings's growth rate over time

Valuation

What is GoodRx Holdings stock price valuation
P/E
66.4
P/B
1.74
P/S
1.43
EV/EBIT
16.73
EV/EBITDA
7.87
EV/Sales
1.75
The price to earnings (P/E) is 59% higher than the last 4 quarters average of 43.3
The company's EPS fell by 44% YoY and by 17% QoQ
GDRX's P/B is 60% below its 5-year quarterly average of 4.5 but 13% above its last 4 quarters average of 1.6
GoodRx Holdings's equity has increased by 4.1% from the previous quarter
The price to sales (P/S) is 69% lower than the 5-year quarterly average of 4.8 but 15% higher than the last 4 quarters average of 1.3

Efficiency

How efficient is GoodRx Holdings business performance
GoodRx Holdings's ROA has plunged by 65% YoY and by 36% from the previous quarter
The company's return on equity fell by 49% YoY and by 21% QoQ
The company's return on invested capital fell by 20% YoY and by 4.7% QoQ
The company's return on sales fell by 17% YoY and by 5% QoQ

Dividends

What is GDRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GDRX.

Financial health

How did GoodRx Holdings financials performed over time
GoodRx Holdings's total assets is 38% more than its total liabilities
The total liabilities has soared by 151% YoY and by 21% QoQ
The quick ratio has plunged by 89% YoY and by 25% from the previous quarter
The debt is 17% less than the equity
GDRX's debt to equity is down by 4.6% since the previous quarter and by 2.4% year-on-year
GoodRx Holdings's equity has increased by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.